Creative Financial Designs’s Teva Pharmaceuticals TEVA Stock Holding History

Creative Financial Designs’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2K	Buy	65 +54	+491%	+$1.8K	﹤0.01%	1882
2026 Q1	$331	Hold	11	–	–	﹤0.01%	2041
2025 Q4	$343	Hold	11	–	–	﹤0.01%	1944
2025 Q3	$222	Sell	11 -33	-75%	-$580	﹤0.01%	1983
2025 Q2	$737	Hold	44	–	–	﹤0.01%	1842
2025 Q1	$676	Hold	44	–	–	﹤0.01%	1865
2024 Q4	$970	Hold	44	–	–	﹤0.01%	1696
2024 Q3	$793	Hold	44	–	–	﹤0.01%	1599
2024 Q2	$715	Hold	44	–	–	﹤0.01%	1565
2024 Q1	$621	Hold	44	–	–	﹤0.01%	1583
2023 Q4	$459	Hold	44	–	–	﹤0.01%	1540
2023 Q3	$449	Hold	44	–	–	﹤0.01%	1445
2023 Q2	$331	Hold	44	–	–	﹤0.01%	1427
2023 Q1	$389	Sell	44 -600	-93%	-$5.93K	﹤0.01%	1348
2022 Q4	$5.87K	Buy	644 +600	+1,364%	+$5.24K	﹤0.01%	1006
2022 Q3	$0	Hold	44	–	–	﹤0.01%	1334
2022 Q2	$0	Hold	44	–	–	﹤0.01%	1332
2022 Q1	$0	Buy	+44	New	+$367	﹤0.01%	1320

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Creative Financial Designs's TEVA Position: Q2 2026 in Review

Creative Financial Designs increased its Teva Pharmaceuticals (TEVA) stake by 491% in Q2 2026, buying an estimated $1.8K and bringing the position to 65 shares worth $2.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1882.

Creative Financial Designs first reported a position in TEVA in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.87K in Q4 2022. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Creative Financial Designs held 65 shares of Teva Pharmaceuticals worth $2.2K as of Q2 2026.
Creative Financial Designs bought 54 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.8K.
Teva Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1882 holding.
Creative Financial Designs first reported a position in Teva Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
Creative Financial Designs's Teva Pharmaceuticals position peaked at $5.87K in Q4 2022.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.